EXTRAORDINARY ITEMS - Being wise before the non-event.
The March issue of Financial Director was already in the post when word came that the £100bn-plus merger between Glaxo Wellcome and SmithKline Beecham was being abandoned - which made our Insight article on the two FDs leading the deal, John Coombe and Hugh Collum, look somewhat pointless.
Leave a Reply
You must be logged in to post a comment.